PharmaSources E-Newsletter August 2021 Issue 1

[Pharma Sources]

View this e-mail (http://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tkaWlm_j.H1tTAyMTsf5GthaGxsZkBAAA27) online

E-Newsletter 
August 2021 

register for free  (https://www.pharmasources.com/service/buyer-membership?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
Home (https://www.pharmasources.com/?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
Products (https://www.pharmasources.com/products?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
Suppliers (https://www.pharmasources.com/suppliers?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
News (https://www.pharmasources.com/news?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)

Editor's Pick

 (https://www.pharmasources.com/news/72807.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)New Breakthrough in the Therapy of Hemophilia: Chinese Recombinant Coagulation Factor VIII has been Approved for Marketing
On July 23, according to latest announcement in the official website of the National Medical Products Administration (NMPA), the recombinant coagulation factor VIII (SCT800) for injection developed by Shenzhou Cell Biotechnology (hereinafter referred to as Shenzhou Cell) has been officially approved.
Read More (https://www.pharmasources.com/news/72807.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)

 (https://www.pharmasources.com/service/buyer-membership?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
More Industry Insights
Drug Research and Development of Targeting STAT3: Next Outlet for Antitumor Drugs (https://www.pharmasources.com/news/72805.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)New Progress of Potential "Specific Drugs" for COVID-19: Masitinib + S2H97 (https://www.pharmasources.com/news/72554.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Bispecific Antibodies – Key Developments in China (https://www.pharmasources.com/news/71742.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
 (https://www.pharmasources.com/company-home/nanjing-redwood-fine-chemical-co-ltd-userId-25577.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Hot Products

 (https://www.pharmasources.com/products/100-nutramax-supplier-rose-hip-extract10-22986.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Rose Hip Extract
 (https://www.pharmasources.com/products/100-nutramax-supplier-andrographis-panic-23031.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Andrographis Paniculata Extract
 (https://www.pharmasources.com/products/100-nutramax-supplier-mangostana-extract-23037.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Mangostana Ectract

 (https://www.pharmasources.com/products/reaction-kettle-258989.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Rection Kettle
 
 (https://www.pharmasources.com/products/jiahang-digital-automatic-analytic-balan-267413.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Jiahang Digital Automatic Analytic Balance
 (https://www.pharmasources.com/products/two-side-tablet-inspection-machine-model-106346.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)Two-side Tablet Inspection Machine

Source More Products (https://www.pharmasources.com/products?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)

 (https://www.pharmasources.com/news/72563.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
We Want You!

Become a Pharma Product Writer (https://www.pharmasources.com/news/64953.html?utm_source=newsletter&utm_medium=email&utm_campaign=enenewsPS0813) for PharmaSources.com to Reach the Right Audience
 (https://www.pharmasources.com/service/supplier-membership?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0813)
Customer Service
(+86) 400 610 1188
PharmaSources at imsinoexpo.com (mailto:PharmaSources at imsinoexpo.com)
unsubscribe (http://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tkaWlm_j.H1tTAyMTsf5GthaGxsZkBAAA27&Z=-2002939221)
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20210813/b6e731fa/attachment-0001.html>